The Use of Oncoplastic Reduction Techniques to Reconstruct Partial Mastectomy Defects in Women with Ductal Carcinoma In Situ

被引:43
作者
Song, Hanjoon M. [1 ]
Styblo, Toncred M. [1 ]
Carlson, Grant W. [1 ]
Losken, Albert [1 ]
机构
[1] Emory Univ, Sch Med, Dept Surg, Div Plast Surg, Atlanta, GA 30308 USA
关键词
ductal carcinoma in situ; oncoplastic surgery; partial mastectomy; reduction mammaplasty; INTRAOPERATIVE MARGIN ASSESSMENT; BREAST-CONSERVATION THERAPY; MAMMAPLASTY SPECIMENS; CONSERVING THERAPY; SURGERY; RECURRENCE; ACCURACY; OUTCOMES; CANCER;
D O I
10.1111/j.1524-4741.2009.00891.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The application of oncoplastic techniques to breast conservation therapy (BCT) is thought to improve cosmetic results with some documented oncologic advantages in certain patients. Although present data highlight the oncologic safety of this approach, the role of oncoplastic surgery specific to ductal carcinoma in situ (DCIS) has not been elucidated. In this study, all women in the Emory Healthcare system between January 1991 and June 2006 with biopsy-proven DCIS who underwent lumpectomies combined with simultaneous reduction mammaplasties or mastopexies were identified. Medical records, including office notes, operative and pathology reports were analyzed. Parameters included age, BMI, histologic grade (low, intermediate, high) and type (comedo versus non-comedo) of DCIS, margin status, locoregional recurrence, specimen weight, postoperative complications, and overall outcomes. Pedicle design and contralateral breast pathology were also analyzed. Twenty-eight women were included in the study with an average age of 47. Therapeutic mammaplasty was the definitive procedure for 18 (64%) of these patients. Ten patients (36%) required reoperations: nine for positive margins and one for residual microcalcifications (stereo biopsy DCIS). Overall, seven patients (25%) required completion mastectomy with reconstruction (transverse rectus abdominus myocutaneous flap: n = 3, latissimus flap: n = 4), whereas three patients (11%) underwent re-excisions with confirmation of negative margins. All ten women who required completion mastectomy or re-excisions exhibited either intermediate or high-grade, comedo DCIS. Overall, 50% (6/12) of women diagnosed with high-grade comedo DCIS required completion mastectomy with reconstruction after initial therapeutic mammaplasty. The final positive-margin rate for women diagnosed with intermediate-grade, comedo necrosis was 43% (3/7). The women in this failed group that required reoperations were overall younger (mean: 45.6; median: 43) than those in which oncoplastic surgery was the definitive procedure (mean: 57.8; median: 57). There were no significant differences between the failed and successful groups in terms of biopsy weight (failed: 253 g, successful: 237 g), type of excision (e.g., wire-localized), location of tumor, reduction type (e.g., superior medial), or postoperative complications. There was one case of locoregional recurrence of DCIS 7 months after the initial operation. All 28 patients had no evidence of disease at an average follow-up of 2.7 years. This study suggests that although oncoplastic reduction techniques are a reasonable approach for women with DCIS, stricter patient selection and improved confirmation of negative margins will minimize the need for either re-excisions or completion mastectomy and reconstruction.
引用
收藏
页码:141 / 146
页数:6
相关论文
共 29 条
[1]   Oncological and cosmetic outcomes of oncoplastic breast conserving surgery [J].
Asgeirsson, KS ;
Rasheed, T ;
McCulley, SJ ;
Macmillan, RD .
EJSO, 2005, 31 (08) :817-823
[2]   Aesthetic outcomes in patients undergoing breast conservation therapy for the treatment of localized breast cancer [J].
Bajaj, AK ;
Kon, PS ;
Berg, KC ;
Miles, DAG .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2004, 114 (06) :1442-1449
[3]   BREAST-TUMORS - COMPARATIVE ACCURACY OF MR-IMAGING RELATIVE TO MAMMOGRAPHY AND US FOR DEMONSTRATING EXTENT [J].
BOETES, C ;
MUS, RDM ;
HOLLAND, R ;
BARENTSZ, JO ;
STRIJK, SP ;
WOBBES, T ;
HENDRIKS, JHCL ;
RUYS, SHJ .
RADIOLOGY, 1995, 197 (03) :743-747
[4]   Role for intraoperative margin assessment in patients undergoing breast-conserving surgery [J].
Cabioglu, Neslihan ;
Hunt, Kelly K. ;
Sahin, Aysegul A. ;
Kuerer, Henry M. ;
Babiera, Gildy V. ;
Singletary, S. Eva ;
Whitman, Gary J. ;
Ross, Merrick I. ;
Ames, Frederick C. ;
Feig, Barry W. ;
Buchholz, Thomas A. ;
Meric-Bernstam, Funda .
ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (04) :1458-1471
[5]   Separate cavity margin sampling at the time of initial breast lumpectomy significantly reduces the need for reexcisions [J].
Cao, DF ;
Lin, C ;
Woo, SH ;
Vang, R ;
Tsangaris, TN ;
Argani, P .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (12) :1625-1632
[6]   Oncoplastic techniques allow extensive resections for breast-conserving therapy of breast carcinomas [J].
Clough, KB ;
Lewis, JS ;
Couturaud, B ;
Fitoussi, A ;
Nos, C ;
Falcou, MC .
ANNALS OF SURGERY, 2003, 237 (01) :26-34
[7]   Occult breast carcinoma in reduction mammaplasty specimens: 14-year experience [J].
Colwell, AS ;
Kukreja, J ;
Breuing, KH ;
Lester, S ;
Orgill, DP .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2004, 113 (07) :1984-1988
[8]   Frequency of clinically occult intraepithelial and invasive neoplasia in reduction mammoplasty specimens: A study of 516 cases [J].
Dotto, Jorge ;
Kluk, Michael ;
Geramizadeh, Bita ;
Tavassoli, Fattaneh A. .
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2008, 16 (01) :25-30
[9]   Local recurrence after breast-conserving therapy for invasive breast cancer: High incidence in young patients and association with poor survival [J].
Elkhuizen, PHM ;
van de Vijver, MJ ;
Hermans, J ;
Zonderland, HM ;
van de Velde, CJH ;
Leer, JWH .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 40 (04) :859-867
[10]   Comparative study of the accuracy of breast resection in oncoplastic surgery and quadrantectomy in breast cancer [J].
Giacalone, Pierre-Ludovic ;
Roger, Pascal ;
Dubon, Olivier ;
El Gareh, Nouredine ;
Rihaoui, Samia ;
Taourel, Patrice ;
Daures, Jean Pierre .
ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) :605-614